Literature DB >> 15879007

Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties.

Bela Kis1, James A Snipes, David W Busija.   

Abstract

Cyclooxygenase (COX)-3, a novel COX splice variant, was suggested as the key to unlocking the mystery of the mechanism of action of acetaminophen. Although COX-3 might have COX activity in canines, and this activity might be inhibited by acetaminophen, its low expression level and the kinetics indicate unlikely clinical relevance. In rodents and humans, COX-3 encodes proteins with completely different amino acid sequences than COX-1 or COX-2 and without COX activity; therefore, it is improbable that COX-3 in these species plays a role in prostaglandin-mediated fever and pain. The aim of this review is to evaluate the literature that seeks to point out critical theoretical and methodological limitations of the COX-3 studies that led several investigators to scientifically questionable conclusions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879007     DOI: 10.1124/jpet.105.085431

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

Review 1.  mRNA transcript diversity creates new opportunities for pharmacological intervention.

Authors:  Elizabeth S Barrie; Ryan M Smith; Jonathan C Sanford; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2012-02-07       Impact factor: 4.436

Review 2.  Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications.

Authors:  Saba Aïd; Francesca Bosetti
Journal:  Biochimie       Date:  2010-09-22       Impact factor: 4.079

Review 3.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

4.  Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans.

Authors:  Nicholas A Burd; Jared M Dickinson; Jennifer K Lemoine; Chad C Carroll; Bridget E Sullivan; Jacob M Haus; Bozena Jemiolo; Scott W Trappe; Gordon M Hughes; Charles E Sanders; Todd A Trappe
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

Review 5.  Oxycodone/paracetamol: a low-dose synergic combination useful in different types of pain.

Authors:  Antonio Gatti; Elisabetta Sabato; Anna Rita Di Paolo; Massimo Mammucari; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 6.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

7.  Aspirin and acetaminophen: should they be available over the counter?

Authors:  Kay Brune; Burkhard Hinz; Ivan Otterness
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 8.  Licofelone: the answer to unmet needs in osteoarthritis therapy?

Authors:  Shrinivas K Kulkarni; Vijay P Singh
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

9.  Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain.

Authors:  R M Rezende; D S França; G B Menezes; W G P dos Reis; Y S Bakhle; J N Francischi
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

10.  The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation.

Authors:  Maria Teresa Valenti; Sandro Giannini; Luca Donatelli; Mirko Zanatta; Francesco Bertoldo; Stefania Sella; Maria Teresa Vilei; Elena Ossi; Giuseppe Realdi; Vincenzo Lo Cascio; Luca Dalle Carbonare
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.